COVID-19:  Screening, updates and safety protocols: 

Dr. Lynn Zhu

Lynn Zhu
Role
Evaluation Researcher, Research and Academics Department

905-430-4055 Ext. 6310
@email

PhD in Population Epidemiology and MSc in Health and Rehabilitation Sciences (Health and Aging specialization) from Western University.

Postdoctoral research fellowships in epidemiology, gerontology, and health service evaluation at the Rotman Research Institute (Baycrest Health Sciences) and Women’s College Research Institute (Women’s College Hospital).

Current adjunct professorship appointment within the Faculty of Health Sciences at Ontario Tech University. 

Areas of Research

1. Health technology assessment (e.g., wearable sensors), evaluation of health interventions (e.g., online cognitive training and therapies, medications) and services (e.g., virtual care delivery, psychotherapy, performance improvement). 
 
2. Geriatrics and gerontology, dementia and neurodegenerative diseases, cognitive and mental wellbeing, health over the life course

3. Health equity and epidemiology, socio-determinants of health
 

Research Team/Collaborators

Toronto Dementia Research Alliance 
Ontario COVID-19 Science Table Mental Health Working Group
Rotman Research Institute, Baycrest Health Sciences
Women’s College Research Institute, Women’s College Hospital
Ecological Mobility in Aging and Parkinson’s Research Group

Recent Publications  

Friesen EL, Kurdyak PA, Gomes T, Kolla G, Leece P, Zhu L, Toombs E, O’Neill B, Stall NM, Jϋni P, Mushquash CJ, Mah L on behalf of the Ontario COVID-19 Science Advisory Table and the Mental Health Working Group. The impact of the COVID-19 pandemic on opioid-related harm in Ontario. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021;2(42). doi: 10.47326/ ocsat.2021.02.42.1.0

Savage RD, Hardacre K, Mahder Bashi A, Bronskill SE, Faulkner C, Grieve J, Gruneir A, McCarthy LM, Chamberlain SA, Lam K, Stall NM, Zhu L, Rochon PA. Perspectives on ageing: a qualitative study of the expectations, priorities, needs and values of older people from two Canadian provinces. Age Ageing. 2021. 50(5): 1811-9. doi:10.1093/ageing/afab136

Mehta N* & Zhu L*, Lam K, Stall NM, Savage R, Read SH, Wu W, Pop P, Faulkner C, Bronskill SE, RochonPA.Health forums and Twitter for dementia research: opportunities and considerations. JAGS. 2020. 68(12): 2881-2889. doi:10.1111/jgs.16790
*co-first authors

Zhu L, Duval C, Boissy P, Montero-Odasso M, Zou GY, JogM, Speechley M. Comparing GPS-basedcommunity mobility measures with self-report assessments in older adults with Parkinson’s disease. JGeron A Biol. Sci. Med. Sci.2020.75(12): 2361-2370. doi:10.1093/gerona/glaa0123. 

Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM. Evaluation of a common prescribing cascade ofcalcium channel blockers and diuretics in older adults with hypertension.JAMA Int Med.2020.180(5): 643-651. doi:10.1001/jamainternmed.2019.70874. 

Lam K, Arnold CG, Savage RD, Stall NM, Zhu L, Wu W, Piggott K, Bronskill SE, Rochon PA. Does physician retirement affect patients? A systematic review. JAGS. 2020. 68(3): 641-649. doi:10.1111/jgs.162165.

Zhu L, Rochon PA, Gruneir A, Wu W, Giannakeas V, Austin PC, Stall N, AlbergaA, McCarthy L, Herrmann N, Gill SS, Bronskill SE. Sex differences in prevalence of cholinesteraseinhibitors and concurrent drug use in older adults. Drugs Aging. 2019.  doi: 10.1007/s40266-019-00690-96. 
Brath H, Mehta N, Savage RD, Gill SS, Wu W, Bronskill SE, Zhu L, Gurwitz JH, Rochon PA. What is knownabout preventing, detecting and reversing prescribing cascades: a scoping review. J Am Geriatr Soc.2018.66(11):2079-2085. doi: 10.1111/jgs.155437. 

Rochon PA, Gruneir A, Bell CM, Savage R, Gill SS, Wu W, Giannakeas V, Stall NM, Seitz DP, Normand S-L, Zhu L, Herrmann N, McCarthy L, Faulkner C, Gurwitz JH, Austin PC, Bronskill SE. Comparison ofprescribing practices for older adults treated by female versus male physicians: a retrospectivecohort study. Plos ONE.2018.13(10):e0205524. doi: 10.1371/journal.pone.02055248. 

Rochon PA, Gruneir A, Gill SS, Wu W, Zhu L, Herrmann N, Bell CM, Austin PC, Stall NM, McCarthy L,Giannakeas V, Alberga A, Seitz DP, Normand S, Gurwitz JH, Bronskill SE. Initial cholinesteraseinhibitor therapy dose and serious events in older women and men. J Am Geriatr Soc.2018.66(9):1692-1699.doi: 10.1111/jgs.1544